Prostate Cancer Coverage from Every Angle

Karim Fizazi, MD, PhD, on Whether or How to Combine Prostate Cancer Treatments

Posted: Monday, June 7, 2021

Karim Fizazi, MD, PhD, of Institut Gustave Roussy, discusses the clinical implications of findings from the PEACE1 study, which explored the use of abiraterone added to androgen deprivation therapy and docetaxel.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.